Literature DB >> 12091483

Interactions of very long-chain saturated fatty acids with serum albumin.

Ji-Kyung Choi1, Jet Ho, Stephen Curry, Donghui Qin, Robert Bittman, James A Hamilton.   

Abstract

The remarkable binding properties of serum albumin have been investigated extensively, but little is known about an important class of fatty acids, the very long-chain saturated fatty acids (VLCFA; >18 carbons). Although VLCFA are metabolized efficiently in normal individuals, they are markers for and possibly causative agents of several peroxisomal disorders. We studied the binding of [(13)C]carboxyl-enriched arachidic (C20:0), behenic (C22:0), lignoceric (C24:0), and hexacosanoic (C26:0) acids to bovine serum albumin (BSA) by (13)C-NMR spectroscopy. For each VLCFA, the NMR spectra showed multiple signals at chemical shifts previously identified for long-chain fatty acids (12-18 carbons), suggesting stabilization of binding by similar, if not identical, interactions of the fatty acid carboxyl anion with basic amino acid residues. The maximal binding (mol of VLCFA/mol of BSA) and the number of observed binding sites decreased with increasing chain length, from 4-5 for C20:0, 3-4 for C22:0, and 2 for C24:0; we validated our previous conclusion that BSA has only one site for C26:0 (Ho, J. K., H. Moser, Y. Kishimoto, and J. A. Hamilton. 1995. J. Clin. Invest. 96: 1455-1463). Analysis of chemical shifts suggested that the highest affinity sites for VLCFA are low affinity sites for long-chain fatty acids. In competition experiments with (13)C-labeled C22:0 (3 mol/mol of BSA) and unlabeled oleic acid, C22:0 bound to BSA in the presence of up to 4 mol of oleic acid/mol of BSA, but 1 mol was shifted into a different site. Our studies suggest that albumin has adequate binding capacity for the low plasma levels of VLCFA with 20 to 26 carbons, but the protein may not be able to bind longer chain VLCFA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091483     DOI: 10.1194/jlr.m200041-jlr200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  23 in total

Review 1.  Evaluation of therapy of X-linked adrenoleukodystrophy.

Authors:  Hugo W Moser; Ali Fatemi; Kathleen Zackowski; Seth Smith; Xavier Golay; Larry Muenz; Gerald Raymond
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

2.  Serum albumin prevents protein aggregation and amyloid formation and retains chaperone-like activity in the presence of physiological ligands.

Authors:  Thomas E Finn; Andrea C Nunez; Margaret Sunde; Simon B Easterbrook-Smith
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

3.  Catalysis of NADH-->NADP+ transhydrogenation by adult Hymenolepis diminuta mitochondria.

Authors:  J P Park; C F Fioravanti
Journal:  Parasitol Res       Date:  2005-12-03       Impact factor: 2.289

4.  Biocompatibility of polysebacic anhydride microparticles with chondrocytes in engineered cartilage.

Authors:  Sathish Ponnurangam; Grace D O'Connell; Clark T Hung; Ponisseril Somasundaran
Journal:  Colloids Surf B Biointerfaces       Date:  2015-08-28       Impact factor: 5.268

5.  Probing three-dimensional structure of bovine serum albumin by chemical cross-linking and mass spectrometry.

Authors:  Bill X Huang; Hee-Yong Kim; Chhabil Dass
Journal:  J Am Soc Mass Spectrom       Date:  2004-08       Impact factor: 3.109

6.  ITC and NMR Analysis of the Encapsulation of Fatty Acids within a Water-Soluble Cavitand and its Dimeric Capsule.

Authors:  Kaiya Wang; Punidha Sokkalingam; Bruce C Gibb
Journal:  Supramol Chem       Date:  2015-10-15       Impact factor: 1.688

7.  CD36 mediates both cellular uptake of very long chain fatty acids and their intestinal absorption in mice.

Authors:  Victor A Drover; David V Nguyen; Claire C Bastie; Yolanda F Darlington; Nada A Abumrad; Jeffrey E Pessin; Erwin London; Daisy Sahoo; Michael C Phillips
Journal:  J Biol Chem       Date:  2008-03-10       Impact factor: 5.157

Review 8.  Fatty acids as therapeutic auxiliaries for oral and parenteral formulations.

Authors:  Michael J Hackett; Jennica L Zaro; Wei-Chiang Shen; Patrick C Guley; Moo J Cho
Journal:  Adv Drug Deliv Rev       Date:  2012-08-17       Impact factor: 15.470

Review 9.  Cell culture models of fatty acid overload: Problems and solutions.

Authors:  Nour Alsabeeh; Bruno Chausse; Pamela A Kakimoto; Alicia J Kowaltowski; Orian Shirihai
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-11-15       Impact factor: 4.698

10.  Binding of PFOS to serum albumin and DNA: insight into the molecular toxicity of perfluorochemicals.

Authors:  Xian Zhang; Ling Chen; Xun-Chang Fei; Yin-Sheng Ma; Hong-Wen Gao
Journal:  BMC Mol Biol       Date:  2009-02-25       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.